V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20028796 | 20012260 | null | 85 | Neo-adjuvant (N) | 2016-01-12 | 2016-01-30 | FEC + DOCETAXEL | N | N | 20101496 | FEC + DOCETAXEL |
| 20028797 | 20012261 | 1.57 | 60 | Adjuvant (A) | 2016-01-01 | 2016-01-08 | FEC + DOCETAXEL | 02 | N | 20101501 | FEC + DOCETAXEL |
| 20028798 | 20012262 | 1.62 | 78 | Adjuvant (A) | 2015-07-10 | 2015-07-10 | FEC + DOCETAXEL | 02 | N | 20101504 | FEC + DOCETAXEL |
| 20028799 | 20012262 | 1.65 | 60.5 | Adjuvant (A) | 2017-07-07 | 2017-07-12 | FEC + DOCETAXEL | 02 | N | 20101504 | FEC + DOCETAXEL |
| 20028800 | 20012263 | 1.6 | 55.6 | Curative (C) | null | 2016-02-07 | FEC + DOCETAXEL | N | N | 20101511 | FEC + DOCETAXEL |
| 20028801 | 20012264 | 1.64 | 86 | Adjuvant (A) | 2017-06-09 | 2017-06-10 | FEC + DOCETAXEL | 02 | N | 20101517 | FEC + DOCETAXEL |
| 20028802 | 20012264 | 1.75 | null | Neo-adjuvant (N) | 2016-05-04 | 2016-05-27 | FEC + DOCETAXEL | N | N | 20101517 | FEC + DOCETAXEL |
| 20028803 | 20012264 | 1.69 | 59 | Adjuvant (A) | 2018-01-24 | 2018-02-01 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20101517 | FEC + DOCETAXEL |
| 20028804 | 20012264 | 1.63 | 65.2 | Adjuvant (A) | 2014-03-10 | 2014-03-18 | FEC + DOCETAXEL | 02 | N | 20101517 | FEC + DOCETAXEL |
| 20028805 | 20012265 | 1.57 | null | Adjuvant (A) | 2013-03-31 | 2013-05-06 | FEC + DOCETAXEL | 2 | N | 20101529 | FEC + DOCETAXEL |
| 20028806 | 20012266 | 1.66 | 92.2 | Neo-adjuvant (N) | 2016-12-03 | 2016-12-21 | FEC 100 + DOCETAXEL | N | N | 20101533 | FEC + DOCETAXEL |
| 20028807 | 20012266 | null | null | Adjuvant (A) | 2014-08-30 | 2014-09-12 | FEC + DOCETAXEL | N | N | 20101533 | FEC + DOCETAXEL |
| 20028808 | 20012267 | 1.61 | 54.3 | Curative (C) | 2017-12-19 | 2018-01-03 | FEC + DOCETAXEL | N | N | 20101542 | FEC + DOCETAXEL |
| 20028809 | 20012267 | null | 77 | null | 2013-03-22 | 2013-04-06 | FEC + DOCETAXEL | N | N | 20101542 | FEC + DOCETAXEL |
| 20028810 | 20012267 | 1.63 | 84.8 | Curative (C) | 2017-01-31 | 2017-01-31 | FEC + DOCETAXEL | 2 | N | 20101542 | FEC + DOCETAXEL |
| 20028811 | 20012267 | 1.71 | 88.8 | Adjuvant (A) | 2016-12-27 | 2017-01-01 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20101542 | FEC + DOCETAXEL |
| 20028812 | 20012267 | 1.52 | null | null | 2013-08-07 | 2013-08-11 | FEC + DOCETAXEL | N | N | 20101542 | FEC + DOCETAXEL |
| 20028813 | 20012268 | 1.55 | 60.4 | Adjuvant (A) | 2015-02-26 | 2015-03-05 | FEC + DOCETAXEL | N | N | 20101565 | FEC + DOCETAXEL |
| 20028814 | 20012268 | 1.67 | null | Palliative (P) | null | 2016-07-24 | FEC 100 + DOCETAXEL | null | null | 20101565 | FEC + DOCETAXEL |
| 20028815 | 20012269 | 1.71 | 78 | Adjuvant (A) | null | 2015-10-27 | FEC + DOCETAXEL | N | null | 20101579 | FEC + DOCETAXEL |
| 20028816 | 20012269 | 1.54 | 101.4 | Neo-adjuvant (N) | 2017-07-25 | 2017-10-30 | FEC + DOCETAXEL | 2 | N | 20101579 | FEC + DOCETAXEL |
| 20028817 | 20012269 | null | 87.7 | null | 2015-04-06 | 2015-04-28 | FEC + DOCETAXEL | N | N | 20101579 | FEC + DOCETAXEL |
| 20028818 | 20012270 | 1.67 | null | Adjuvant (A) | 2017-05-30 | 2017-06-20 | FEC + DOCETAXEL | N | null | 20101594 | FEC + DOCETAXEL |
| 20028819 | 20012270 | null | 64.3 | Adjuvant (A) | 2013-06-03 | 2013-06-20 | FEC 100 + DOCETAXEL | N | N | 20101594 | FEC + DOCETAXEL |
| 20028820 | 20012270 | null | 95.05 | null | 2017-01-29 | 2017-02-03 | FEC + DOCETAXEL | N | N | 20101594 | FEC + DOCETAXEL |
| 20028821 | 20012270 | 1.67 | null | Adjuvant (A) | 2014-11-13 | 2014-11-13 | FEC 100 + DOCETAXEL | N | N | 20101594 | FEC + DOCETAXEL |
| 20028822 | 20012270 | 1.72 | 103 | Neo-adjuvant (N) | 2015-01-22 | 2015-01-24 | FEC + DOCETAXEL | 02 | N | 20101594 | FEC + DOCETAXEL |
| 20028823 | 20012270 | 1.76 | 76 | Not known (9) | 2017-08-05 | 2017-08-19 | FEC + DOCETAXEL | N | N | 20101594 | FEC + DOCETAXEL |
| 20028824 | 20012271 | null | 59.4 | null | 2013-09-27 | 2013-10-13 | FEC + DOCETAXEL | 2 | n | 20101615 | FEC + DOCETAXEL |
| 20028825 | 20012271 | 1.67 | 77.6 | Not known (9) | 2014-11-04 | 2014-11-22 | FEC 100 + DOCETAXEL | N | N | 20101615 | FEC + DOCETAXEL |
| 20028826 | 20012272 | 1.74 | 116 | Neo-adjuvant (N) | 2015-09-28 | 2015-10-06 | FEC + DOCETAXEL | 2 | N | 20101618 | FEC + DOCETAXEL |
| 20028827 | 20012272 | 1.58 | 82 | Adjuvant (A) | 2016-06-30 | 2016-06-30 | FEC + DOCETAXEL | 02 | N | 20101618 | FEC + DOCETAXEL |
| 20028828 | 20012273 | 1.58 | 91 | Adjuvant (A) | 2017-09-19 | 2017-09-19 | FEC 100 + DOCETAXEL | N | N | 20101620 | FEC + DOCETAXEL |
| 20028829 | 20012273 | 1.74 | 59.9 | Adjuvant (A) | 2016-05-09 | 2016-05-19 | FEC + DOCETAXEL | 02 | N | 20101620 | FEC + DOCETAXEL |
| 20028830 | 20012274 | 1.67 | 55.5 | Adjuvant (A) | 2013-12-28 | 2014-01-05 | FEC 100 + DOCETAXEL | 2 | N | 20101627 | FEC + DOCETAXEL |
| 20028831 | 20012274 | 1.55 | 74 | Neo-adjuvant (N) | 2015-12-19 | 2015-12-20 | FEC + DOCETAXEL | 02 | N | 20101627 | FEC + DOCETAXEL |
| 20028832 | 20012275 | 1.6 | 103.1 | Neo-adjuvant (N) | null | 2017-07-31 | FEC 100 + DOCETAXEL | 2 | N | 20101630 | FEC + DOCETAXEL |
| 20028833 | 20012275 | 1.66 | 127 | Not known (9) | 2017-04-05 | 2017-04-06 | FEC + DOCETAXEL | 02 | N | 20101630 | FEC + DOCETAXEL |
| 20028834 | 20012276 | 1.68 | 68 | Adjuvant (A) | 2018-02-22 | 2018-02-25 | FEC + DOCETAXEL | 2 | N | 20101634 | FEC + DOCETAXEL |
| 20028835 | 20012276 | null | 98 | Adjuvant (A) | null | 2014-01-03 | FEC + DOCETAXEL | 99 | null | 20101634 | FEC + DOCETAXEL |
| 20028836 | 20012277 | 1.6 | 106.5 | Neo-adjuvant (N) | 2016-07-06 | 2016-07-13 | FEC 100 + DOCETAXEL | N | N | 20101641 | FEC + DOCETAXEL |
| 20028837 | 20012277 | 1.74 | 72.8 | Adjuvant (A) | 2015-04-12 | 2015-04-27 | FEC + DOCETAXEL | 2 | N | 20101641 | FEC + DOCETAXEL |
| 20028838 | 20012277 | 1.69 | 165.8 | Neo-adjuvant (N) | 2013-06-25 | 2013-06-26 | FEC + DOCETAXEL | 2 | N | 20101641 | FEC + DOCETAXEL |
| 20028839 | 20012277 | 1.71 | 60.8 | Not known (9) | 2016-09-09 | 2016-09-12 | FEC + DOCETAXEL | 02 | N | 20101641 | FEC + DOCETAXEL |
| 20028840 | 20012277 | 1.65 | 62.4 | Not known (9) | 2014-12-18 | 2014-12-18 | FEC + DOCETAXEL | 02 | N | 20101641 | FEC + DOCETAXEL |
| 20028841 | 20012278 | 1.7 | 47.45 | Adjuvant (A) | 2016-05-20 | 2016-06-09 | FEC 100 + DOCETAXEL | N | N | 20101656 | FEC + DOCETAXEL |
| 20028842 | 20012278 | 1.67 | 60 | Adjuvant (A) | 2015-08-10 | 2015-08-25 | FEC 100 + DOCETAXEL | N | N | 20101656 | FEC + DOCETAXEL |
| 20028843 | 20012279 | 1.63 | 66 | Curative (C) | 2018-02-17 | 2018-02-17 | FEC + DOCETAXEL | 02 | null | 20101664 | FEC + DOCETAXEL |
| 20028844 | 20012279 | 1.56 | 63 | Curative (C) | 2015-01-21 | 2015-02-02 | FEC + DOCETAXEL | 2 | N | 20101664 | FEC + DOCETAXEL |
| 20028845 | 20012280 | 1.56 | 78.55 | Adjuvant (A) | 2016-05-04 | 2016-05-10 | FEC + DOCETAXEL | N | N | 20101679 | FEC + DOCETAXEL |